From NDTV
Center-Right Owned by Adani Group (AMG Media)Alembic Pharma's Stock Hits Upper Circuit After Q2 Profit Zooms Over 81%
What each side is saying
One outlet's own words from each side of the spectrum. Quoted, not summarised.
-
right · 2 outlets
The pharma player's consolidated bottom-line rose 81.1% to Rs 335 crore in the September quarter from Rs 185 crore in the year-ago period.
— NDTV
RSS excerpt
The pharma player's consolidated bottom-line rose 81.1% to Rs 335 crore in the September quarter from Rs 185 crore in the year-ago period.